Management of benign and aggressive intracranial meningiomas

ONCOLOGY

Volumn 10, Issue 5, 1996, Pages 747-756

  Akeyson, Edward W ^a   McCutcheon, Ian E ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; CISPLATIN; DACARBAZINE; DOXORUBICIN; HORMONE; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; MIFEPRISTONE; PROGESTERONE; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON;

HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MENINGIOMA; REVIEW;

DNA, NEOPLASM; FEMALE; GONADAL STEROID HORMONES; HUMANS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PREGNANCY;

EID: 0029940426     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. Cushing H, Eisenhardt L: Meningiomas: Their Classification, Regional Behavior, Life History and Surgical End Results. Springfield, Illinois, Charles C. Thomas, 1938.
2. Russell DS, Rubenstein LJ: Pathology of Tumors of the Nervous System, pp 449-532, Baltimore, Williams & Wilkins, 1989.
3. de la Monte SM, Flickinger J, Linggood RM. Histopathologic features predicting recurrence of meningiomas following subtotal resection. Am J Surg Pathol 10:836-843, 1986.
4. Zülch KJ: Histological typing of tumours of the central nervous system. International Histological Classification of Tumors, no. 21. Geneva, World Health Organization, pp 53-56, 1979.
5. Kleihues P, Burger PC, Scheithauer BW: Histological Typing of Tumours of the Central Nervous System Berlin, Springer-Verlag, pp 33-37, 1993.
6. Jääskeläinen J, Haltia M, Laasonen E, et al: The growth rate of intracranial meningiomas and its relation to histology. An analysis of 43 patients. Surg Neurol 24:165-172, 1985.
7. Rohringer M, Sutherland GR, Louw GF, et al: Incidence and clinicopathological features of meningioma. J Neurosurg 71:665-672, 1989.
8. Mahmood A, Caccamo DV, Tomecek FJ, et al: Atypical and malignant meningiomas. A clinicopathological review. Neurosurgery 33:955-963, 1993
9. Ironside JW, Battersby RDE, Lawry J, et al DNA in meningioma tissues and explant cell cultures: A flow cytometric study with clinicopathological correlates. J Neurosurg 66:588-594, 1987.
10. Crone KR, Challa VR, Klute TE, et al: Relationship between flow cytometric features and clinical behavior of meningiomas Neurosurgery 23:720-724, 1988.
11. May PL, Broome JC, Lawry J, et al: The prediction of recurrence in meningioma A flow cytometric study of paiaffin-embedded archival material. J Neurosurg 71:347-351, 1989.
12. Shibuya M, Hoshino T, Ito S, et al: Meningiomas. Clinical implications of a high proliferative potential determined by bromodeoxyuridine labeling Neurosurgery 30:494-498, 1992.
13. Fukui M, Iwaki T, Sawa H, et al: Proliferative activity of meningiomas as evaluated by bromodeoxyuridine uptake examination. Acta Neurochir 81.135-141, 1986
14. Jääskeläinen J, Haltia M, Servo A: Atypical and anaplastic meningiomas. Radiology, surgery, radiotherapy, and outcome. Surg Neurol 25:233-242, 1986.
15. Wilson CB: Meningiomas. Genetics, malignancy, and the role of radiation in induction and treatment. J Neurosurg 81:666-675, 1994.
16. Fabiani A, Trebini F, Favero M, et al: The significance of atypical mitoses in malignant meningiomas. Acta Neuropath 38:229-237, 1977.
17. Jellinger K, Slowik F: Histologic subtypes and prognostic problems in meningiomas. J Neurol 208:279-298, 1975.
18. Zülch KJ, Mennel HD. Malignant meningiomas, in Klug W, Brock M, Klinger M et al (eds). Advances in Neurosurgery, pp 3-11, New York, Springer-Verlag, 1975
19. MacCarty CS, Taylor WF: Intracranial meningiomas. Experiences at the Mayo Clinic. Neurol Med Chti (Tokyo) 19:569-574, 1979.
20. Salcman M: Malignant meningiomas, in Al-Mefty O (ed): Meningiomas, pp 75-85. New York, Raven Press., 1991.
21. Wong G, Harper C: Atypical meningiomas. Clinical pathological correlation Aust NZ J Surg 54:331-336, 1984.
22. Thomas HG, Dolman CL, Berry K: Malignant meningioma. Clinical and pathologic features. J Neurosurg 55:929-934, 1981
23. Manelfe C, Lasjaunias P, Ruscalleda J: Preoperative embolization of intracranial meningiomas. Amer Jnl Neuroradiology 7:963-972, 1986.
24. Berenstein A, Kricheff I: Microembolization techniques of vascular occlusion: Radiologic, pathologic and clinical correlation. Am J Neuroradiol 2:261-267, 1981.
25. Rodesch G, Lasjaunias P: Embolization and meningiomas, in Al-Mefty O (ed): Meningiomas. pp 285-297. New York, Raven Press, 1991.
26. Black PM: Meningiomas. Neurosurgery 32.643-657, 1993.
27. Simpson D: The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22-39, 1957.
28. Jan M, Bazeze V, Saudeau D, et al: Outcome of intracranial meningioma in adults: Retrospective study of a medicosurgical series of 161 meningiomas. Neurochirurgie 32:129-134, 1986.
29. Kallio M, Sankilla R, Hakulinen T: Factors affecting operative and excess long-term mortality in 935 patients with intracranial meningiomas. Neurosurgery 31:2-12, 1992.
30. Mirimanoff RO, Dosoretz DE, Linggood RM, et al: Meningiomas: Analysis of recurrence and progression following neurosurgical resection J Neurosurg 62:18-24, 1985.
31. Pertuiset B, Farah S, Clayes L, et al. Operability of intracranial meningiomas: Personal series of 353 cases Acta Neurochirurg 76:2-11, 1985.
32. Sankila R, Kallio M, Jääskeläinen J, et al: Long-term survival of 1986 patients with intracranial meningioma diagnosed from 1953 to 1984 in Finland: Comparison of the observed and expected survival rates in a population-based series. Cancer 70:1568-1576, 1992.
33. Chan RC, Thompson GB: Morbidity, mortality, and quality of life following surgery for intracranial meningiomas: A retrospective study in 257 cases. J Neurosurg 60:52-60, 1984.
34. Dolenc VV: The Cavernous Sinus: A Multidisciplinary Approach to Vascular and Tumorous Lesions. Vienna. Springer-Verlag, 1987.
35. Bricolo AP, Turazzi S, Talachhi A, et al. Microsurgical removal of petroclival meningiomas: A report of 33 patients Neurosurgery 31:813-828, 1992.
36. Sekhar LN, Altschuler EM. Meningiomas of the cavernous sinus, in Al-Mefty O (ed): Meningiomas, pp 445-460. New York, Raven Press, 1991.
37. Sekhar LN, Janetta PJ, Burkhart LE, et al: Meningiomas involving the clivus: A six-year experience with 41 patients. Neurosurgery 27:764-781, 1990.
38. New PFJ, Hesselink JR, O'Carroll CP, et al: Malignant meningiomas: CT and histologic criteria Amer Jnl Neuroradiology 3:267-276, 1982.
39. Kepes JJ: Meningiomas; Biology, Pathology, and Differential Diagnosis, pp 112-123. New York, Masson, 1982.
40. Adegbite AB, Khan MI, Paine KW, et al: The recurrence of intracranial meningiomas after surgical treatment. J Neurosurg 58:51-56, 1983.
41. Barbaro NM, Gutin PH. Wilson CB, et al: Radiation therapy in the treatment of partially resected meningiomas. Neurosurgery 20:525-528, 1987.
42. Bloom HJG. Intracranial tumors. Response and resistance to therapeutic endeavors, 1970-1980. Int J Radiat Oncol Biol Phys 8:1083-1113, 1982.
43. Carella RJ, Ransohoff J, Newall J: Role of radiation therapy in the management of meningioma. Neurosurg 10:332-339, 1982.
44. Forbes AR, Goldberg ID: Radiation therapy in the treatment of meningioma: The Joint Center for Radiation Therapy experience 1970 to 1982. J Clin Oncol 2 1139-1143, 1984.
45. Melamed S, Sahar A, Beller AJ: The recurrence of intracranial meningiomas. Neurochirurgica 22 47-51, 1979.
46. Petty AM, Kun LE, Meyer GA: Radiation therapy for incompletely resected meningiomas. J Neurosurg 62:502-507, 1985.
47. Taylor BW. Jr., Marcus RB, Jr. Friedman WA, et al: The meningioma controversy: Postoperative radiation therapy. Int J Radiat Oncol Biol Phys 15:299-304, 1988.
48. Wara WM: Radiation therapy for brain tumors. Cancer 55: 2291-2295, 1985.
49. Yamashita J, Handa H, Iwaki K et al: Recurrence of intracramal meningiomas. with special reference to radiotherapy. Surg Neurol 14:33-40, 1980.
50. Goldsmith BJ, Wara WM, Wilson CB, et al: Postoperative irradiation for subtotally resected meningiomas: A retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg 80:195-201, 1994.
51. Miralbell R, Linggood RM, de la Monte SM, et al: The role of radiotherapy in the treatment of subtotally resected benign meningiomas. J Neurooncol 13:157-164, 1992.
52. Salazar OM: Ensuring local control in meningiomas Int J Radiat Oncol Biol Phys 15:501-504, 1988.
53. Solan MJ, Kramer S: The role of radiation therapy in the management of intracranial meningiomas. Int J Radiat Oncol Biol Phys 11:675-677, 1985.
54. Kondziolka D, Lunsford LD, Coffey RJ, et al: Stereotactic radiosurgery of meningiomas. J Neurosurg 74:552-559, 1991.
55. Gutin PH, Leibel SA, Hosobuchi Y, et al: Brachytherapy of recurrent tumors of the skull base and spine with iodine-125 sources. Neurosurgery 20:938-945, 1987.
56. Kumar PP, Patil AA, Syh HW, et al. Role of brachytherapy in the management of the skull base meningioma: Treatment of skull base meningiomas. Cancer 71:3726-3731, 1993.
57. Kumar PP, Patil AA, Leibrock LG, et al: Continuous low dose rate brachytherapy with high activity iodine-125 seeds in the management of meningiomas. Int J Radiat Oncol Biol Phys 25:325-328, 1993.
58. Kumar PP, Patil AA, Leibrock LG, et al: Brachytherapy: A viable alternative in the management of basal meningiomas. Neurosurgery 29:676-680, 1991.
59. Al-Mefty O, Schenck MP, and Smith RR: Petroclival meningiomas, in Rengachary SS, Wilkins RH (eds). Neurosurgical Operative Atlas, pp 339-350. Baltimore, Williams & Wilkins, 1991
60. Groves MD, DeMonte F, Yung WAK: Chemotherapeutic treatment of aggressive meningeal tumors (abstract). Skull Base Surgery 5(suppl 1):2, 1995.
61. Stewart DJ, Dahrouge S, Wee M, et al: Intraarterial cisplatin plus intravenous doxorubicin for inoperable recurrent meningiomas. J Neurol Oncol 24:189-194, 1995
62. Bernstein M, Villamil A, Davidson G, et al: Necrosis in a meningioma following systemic chemotherapy: Case report. J Neurosurg 81.284-287, 1994.
63. Sutherland GR, Florell R, Louw D, et al: Epidemiology of primary intracranial neoplasms in Manitoba, Canada. Can J Neurol Sci 14:586-1987.
64. Olson JJ. Laboratory evidence for the hormonal dependency of meningiomas Hum Reprod 9(suppl 1):195-201, 1994.
65. McCormick PW, Coccia C: Coagulopathy, cerebrovascular disease, and other conditions associated with meningiomas, in Schmidek HH (ed): Meningiomas and Their Surgical Management, pp 22-33. Philadelphia, WB Saunders, 1991.
66. Schoenherg BS, Christine BW, Wisnant JP: Nervous system neoplasms and primary malignancies of other sites: The unique association between meningiomas and breast cancer. Neurology 25:705-712, 1975.
67. Jacobs DH, MacFarlane MJ, Holmes FF: Female patients with meningiomas of the sphenoid wing and additional neoplasms of the breast and genital tract. Cancer 60:3080-1987.
68. Donnell MS, Meyer GA, Donegan WL: Oestrogen-receptor proteins in intracranial meningiomas. J Neurosurg 50:499-502, 1979.
69. Cahill DW, Bashirelahi N, Solomon LW, et al: Oestrogen and progesterone receptors in meningiomas J Neurosurg 60:985-993, 1984.
70. Lesch KP, Fahlbusch R: Simultaneous estradiol and progesterone receptor analysis in meningiomas Surg Neurol 26:257-263, 1985
71. Markwalder TM, Zava DT, Goldhirsch A, et al: Oestrogen and progesterone receptors in meningiomas in relation to clinical and pathologic features. Surg Neurol 20:42-47, 1983.
72. Schnegg JF, Gomez F, Lemarchand-Bauraud T, et al: Presence of sex steroid receptors in meningioma tissue. Surg Neurol 15:415-418, 1981.
73. Tilzer LL, Plapp FV, Evans JP, et al: Steroid receptor proteins in human meningiomas Cancer 49:633-636, 1982.
74. Lesch KP, Engl HG, Gross S: Androgen receptor binding activity in meningiomas. Surg Neurol 28:176-180, 1987.
75. Olson JJ, Beck DW, Maclndoe JW, et al: Androgen receptors in meningiomas. Cancer 61:952-955, 1988
76. Markwalder TM, Seiler RW, Zava DT: Antiestiogenic therapy of meningiomas: A pilot study. Surg Neurol 24:245-249, 1985.
77. Goodwin JW, Crowley J, Eyre JH, et al: A phase II evaluation of tamoxifen in unrescetable or refractory meningiomas: A Southwest Oncology Group study. J Neuro Oncol 15:75-77, 1993.
78. Jäaskeläinen J, Laasonen E, Karkkainen J, et al: Hormone treatment of meningiomas: Lack of response to medroxyprogesterone acetate (MPA): A pilot study of five cases. Acta Neurochir 80:35-41, 1986
79. Grunberg SM, Weiss MH: Lack of efficacy of megestrol acetate in the treatment of unresectable meningioma J Neuro-Oncol 8:61-65, 1990.
80. van Seters AP, van Dulken H, de Keizer RJW, et al: Symptomatic relief of meningioma by buserelin maintenance therapy. Lancet 1.564-565, 1989.
81. Grunberg SM: Role of antiprogestational therapy for meningiomas. Hum Reprod 9 (suppl 1).202-207, 1994.
82. Grunberg SM, Weiss MH, Spitz IM, et al: Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone. J Neurosurg 74:861-866, 1991.
83. Lamberts SW, Tanghe HL, Avezaat CJ et al: Mifepristone (RU 4861 treatment of meningiomas. J Neurol Neurosurg Psychiatry 55.486-490, 1992.
84. Haak HR, de Keizer RJ, Hagenouw-Taal JC, et al: Successful mifepristone treatment of recurrent, inoperable meningioma. Lancet 336:124-125, 1990.
85. Fukui M, Kitamura K, Nakagaki H, et al. Irradiated meningiomas: A clinical evaluation. Acta Neurochir 54:33-43, 1980.